Please try another search
For the three months ended 31 December 2017, Trimedyne, Inc. revenues increased 40% to $1.5M. Net income totaled $86K vs. loss of $225K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Selling, general and administrative decrease of 6% to $373K (expense), Research and development decrease of 16% to $75K (expense), Other Expenses.
Period Ending: | Dec 31, 2017 | Dec 31, 2016 | Jun 30, 2016 | Mar 31, 2016 |
---|---|---|---|---|
Total Revenue | 1.53 | 1.09 | 1.11 | 1.26 |
Gross Profit | 0.53 | 0.26 | 0.45 | 0.4 |
Operating Income | 0.08 | -0.23 | -0.12 | -0.19 |
Net Income | 0.09 | -0.23 | -0.12 | -0.12 |
Period Ending: | Dec 31, 2017 | Dec 31, 2016 | Jun 30, 2016 | Mar 31, 2016 |
---|---|---|---|---|
Total Assets | 3.86 | 3.3 | 3.4 | |
Total Liabilities | 1.28 | 0.7 | 0.68 | |
Total Equity | 2.58 | 2.6 | 2.72 |
Period Ending: | Dec 31, 2017 | Dec 31, 2016 | Jun 30, 2016 | Mar 31, 2016 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 9 Months | 6 Months |
Cash From Operating Activities | -0.04 | 0.19 | ||
Cash From Investing Activities | 0 | 0 | ||
Cash From Financing Activities | -0.09 | -0.06 | ||
Net Change in Cash | -0.13 | 0.14 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review